Abstract
Hemophilia is a rare congenital bleeding disorder which has a substantial negative impact on patients’ health-related quality of life (HRQOL). Currently, it is estimated approximately 39,000 patients live with hemophilia in China. However, little is known about Chinese hemophilia patients’ HRQOL. The aim of this study was to measure the HRQOL of patient with hemophilia in China.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
